After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
XFOR belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of X4 Pharmaceuticals Inc is $51.23M. A total of 1.17 million shares were traded on the day, compared to an average of 3.67M shares.
In the most recent transaction, Baldry Mark bought 21,646 shares of XFOR for 0.68 per share on May 17 ’24. After the transaction, the Chief Commercial Officer now owns 115,769 company shares. In a previous transaction on Nov 15 ’24, Baldry Mark bought 13,404 shares at 0.34 per share. XFOR shares that Chief Commercial Officer owns now total 129,173.
Among the insiders who sold shares, Ragan Paula disposed of 76,473 shares on Jan 24 ’25 at a per-share price of $0.45. This resulted in the President and CEO holding 1,087,386 shares of XFOR after the transaction. In another insider transaction, Mostafa Adam S. sold 74,773 shares at $0.45 per share on Jan 24 ’25. Company shares held by the Chief Financial Officer now total 0.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, XFOR has a high of $1.60 and a low of $0.26.
As of this writing, XFOR has an earnings estimate of -$0.16 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.13 per share and a lower estimate of -$0.17.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. XFOR’s latest balance sheet shows that the firm has $81.79M in Cash & Short Term Investments as of fiscal 2021. There were $39.78M in debt and $14.02M in liabilities at the time. Its Book Value Per Share was $0.35, while its Total Shareholder’s Equity was $64.41M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for XFOR is Buy with a score of 5.00.
